# A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

> clinical trial · VERIFIED · 2026-07-28

Status: RECRUITING · Sponsor: Memorial Sloan Kettering Cancer Center · Condition: Myelofibrosis

- Company: Memorial Sloan Kettering Cancer Center
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06773195

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.